Catalyst Wire Dossier Catalyst Wire Dossier

Platelet-poor plasma fibrin hydrogel

platelet-poor plasma fibrin hydrogel · A.A. Partners, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Platelet-poor plasma fibrin hydrogel, covering 2017-04-26 to 2017-04-26. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs) [Phase 1, Phase 2]

See pricing